CTSO logo

CTSO
Cytosorbents Corp

2,139
Mkt Cap
$28.89M
Volume
115,360.00
52W High
$1.39
52W Low
$0.435
PE Ratio
-2.42
CTSO Fundamentals
Price
$0.4608
Prev Close
$0.46
Open
$0.46
50D MA
$0.5995
Beta
0.75
Avg. Volume
63,698.00
EPS (Annual)
-$0.1317
P/B
13.18
Rev/Employee
$287,310.08
$62.91
Loading...
Loading...
News
all
press releases
Transcript: CytoSorbents Q1 2026 Earnings Conference Call
read more...
News Placeholder
More News
News Placeholder
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and...
News Placeholder
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights PR Newswire...
News Placeholder
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business...
News Placeholder
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical...
News Placeholder
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent...
News Placeholder
What Analysts Are Saying About CytoSorbents Stock
read more...
News Placeholder
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and...
News Placeholder
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday...
News Placeholder
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available